• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌动蛋白对G蛋白偶联受体激酶5(GRK5)的调节。

Regulation of G protein-coupled receptor kinase 5 (GRK5) by actin.

作者信息

Freeman J L, De La Cruz E M, Pollard T D, Lefkowitz R J, Pitcher J A

机构信息

Howard Hughes Medical Institute and Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

J Biol Chem. 1998 Aug 7;273(32):20653-7. doi: 10.1074/jbc.273.32.20653.

DOI:10.1074/jbc.273.32.20653
PMID:9685424
Abstract

G protein-coupled receptor kinases (GRKs) initiate pathways leading to the desensitization of agonist-occupied G-protein-coupled receptors (GPCRs). Here we report that the cytoskeletal protein actin binds and inhibits GRK5. Actin inhibits the kinase activity directly, reducing GRK5-mediated phosphorylation of both membrane-bound GPCRs and soluble substrates. GRK5 binds actin monomers with a Kd of 0.6 microM and actin filaments with a Kd of 0. 2 microM. Mutation of 6 amino acids near the amino terminus of GRK5 eliminates actin-mediated inhibition of GRK5. Calmodulin has previously been shown to bind to the amino terminus of GRK5 (Pronin, A. N., and Benovic, J. L. (1997) J. Biol. Chem. 272, 3806-3812) and here we show calmodulin displaces GRK5 from actin. Calmodulin inhibits GRK5-mediated phosphorylation of GPCRs, but not soluble substrates such as casein. Thus in the presence of actin, calmodulin determines the substrate specificity of GRK5 by preferentially allowing phosphorylation of soluble substrates over membrane-bound substrates.

摘要

G蛋白偶联受体激酶(GRKs)启动导致激动剂占据的G蛋白偶联受体(GPCRs)脱敏的信号通路。在此我们报告细胞骨架蛋白肌动蛋白结合并抑制GRK5。肌动蛋白直接抑制激酶活性,减少GRK5介导的膜结合GPCRs和可溶性底物的磷酸化。GRK5与肌动蛋白单体结合的解离常数(Kd)为0.6微摩尔,与肌动蛋白丝结合的Kd为0.2微摩尔。GRK5氨基末端附近6个氨基酸的突变消除了肌动蛋白介导的对GRK5的抑制。此前已证明钙调蛋白与GRK5的氨基末端结合(普罗宁,A.N.,和贝诺维奇,J.L.(1997年)《生物化学杂志》272,3806 - 3812),在此我们表明钙调蛋白将GRK5从肌动蛋白上置换下来。钙调蛋白抑制GRK5介导的GPCRs磷酸化,但不抑制诸如酪蛋白等可溶性底物的磷酸化。因此,在肌动蛋白存在的情况下,钙调蛋白通过优先允许可溶性底物而非膜结合底物的磷酸化来决定GRK5的底物特异性。

相似文献

1
Regulation of G protein-coupled receptor kinase 5 (GRK5) by actin.肌动蛋白对G蛋白偶联受体激酶5(GRK5)的调节。
J Biol Chem. 1998 Aug 7;273(32):20653-7. doi: 10.1074/jbc.273.32.20653.
2
Regulation of G protein-coupled receptor kinases by calmodulin and localization of the calmodulin binding domain.钙调蛋白对G蛋白偶联受体激酶的调节及钙调蛋白结合结构域的定位
J Biol Chem. 1997 Jul 18;272(29):18273-80. doi: 10.1074/jbc.272.29.18273.
3
Phosphatidylinositol 4,5-bisphosphate (PIP2)-enhanced G protein-coupled receptor kinase (GRK) activity. Location, structure, and regulation of the PIP2 binding site distinguishes the GRK subfamilies.磷脂酰肌醇4,5-二磷酸(PIP2)增强G蛋白偶联受体激酶(GRK)的活性。PIP2结合位点的位置、结构和调节区分了GRK亚家族。
J Biol Chem. 1996 Oct 4;271(40):24907-13. doi: 10.1074/jbc.271.40.24907.
4
Structure-function analysis of G protein-coupled receptor kinase-5. Role of the carboxyl terminus in kinase regulation.G蛋白偶联受体激酶-5的结构-功能分析。羧基末端在激酶调节中的作用。
J Biol Chem. 1998 Nov 20;273(47):31510-8. doi: 10.1074/jbc.273.47.31510.
5
Regulation of the G protein-coupled receptor kinase GRK5 by protein kinase C.蛋白激酶C对G蛋白偶联受体激酶GRK5的调控。
J Biol Chem. 1997 Feb 7;272(6):3806-12. doi: 10.1074/jbc.272.6.3806.
6
Inhibition of G protein-coupled receptor kinase subtypes by Ca2+/calmodulin.钙/钙调蛋白对G蛋白偶联受体激酶亚型的抑制作用。
J Biol Chem. 1996 Nov 8;271(45):28691-6. doi: 10.1074/jbc.271.45.28691.
7
Localization of the sites for Ca2+-binding proteins on G protein-coupled receptor kinases.G蛋白偶联受体激酶上钙结合蛋白位点的定位
Biochemistry. 1998 Sep 29;37(39):13650-9. doi: 10.1021/bi980998z.
8
Expression, purification, and characterization of the G protein-coupled receptor kinase GRK5.G蛋白偶联受体激酶GRK5的表达、纯化及特性分析
J Biol Chem. 1994 Jan 14;269(2):1099-105.
9
G protein-coupled receptor kinase 5 contains a DNA-binding nuclear localization sequence.G蛋白偶联受体激酶5含有一个DNA结合核定位序列。
Mol Cell Biol. 2004 Dec;24(23):10169-79. doi: 10.1128/MCB.24.23.10169-10179.2004.
10
alpha-Actinin is a potent regulator of G protein-coupled receptor kinase activity and substrate specificity in vitro.α-辅肌动蛋白在体外是G蛋白偶联受体激酶活性和底物特异性的有效调节剂。
FEBS Lett. 2000 May 19;473(3):280-4. doi: 10.1016/s0014-5793(00)01543-x.

引用本文的文献

1
GRK5 is a regulator of fibroblast activation and cardiac fibrosis.GRK5 是成纤维细胞活化和心脏纤维化的调节因子。
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5). doi: 10.1073/pnas.2012854118.
2
GRK5 - A Functional Bridge Between Cardiovascular and Neurodegenerative Disorders.GRK5——心血管疾病与神经退行性疾病之间的功能桥梁。
Front Pharmacol. 2018 Dec 17;9:1484. doi: 10.3389/fphar.2018.01484. eCollection 2018.
3
TRPV1 is a physiological regulator of μ-opioid receptors.辣椒素受体 TRPV1 是 μ 阿片受体的生理调节剂。
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13561-13566. doi: 10.1073/pnas.1717005114. Epub 2017 Dec 4.
4
Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor Kinase 4.G蛋白偶联受体激酶4高血压变体A486V的结构与功能
J Biol Chem. 2015 Aug 14;290(33):20360-73. doi: 10.1074/jbc.M115.648907. Epub 2015 Jul 1.
5
The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.G蛋白偶联受体激酶在心脏健康与疾病中的演变影响。
Physiol Rev. 2015 Apr;95(2):377-404. doi: 10.1152/physrev.00015.2014.
6
Overlapping and distinct roles of GRK5 in TLR2-, and TLR3-induced inflammatory response in vivo.GRK5 在 TLR2 和 TLR3 诱导的体内炎症反应中具有重叠和独特的作用。
Cell Immunol. 2012;272(2):107-11. doi: 10.1016/j.cellimm.2011.10.019. Epub 2011 Oct 28.
7
GRK5 promotes F-actin bundling and targets bundles to membrane structures to control neuronal morphogenesis.GRK5 促进 F- 肌动蛋白的成束,并将束靶向到膜结构,以控制神经元形态发生。
J Cell Biol. 2011 Sep 19;194(6):905-20. doi: 10.1083/jcb.201104114.
8
G-protein-coupled-receptor kinases mediate TNFα-induced NFκB signalling via direct interaction with and phosphorylation of IκBα.G 蛋白偶联受体激酶通过与 IκBα 的直接相互作用和磷酸化介导 TNFα 诱导的 NFκB 信号通路。
Biochem J. 2009 Dec 14;425(1):169-78. doi: 10.1042/BJ20090908.
9
Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure.心力衰竭中心脏肾上腺素能网络内基因变异的药物基因组学效应机制。
Mol Pharmacol. 2009 Sep;76(3):466-80. doi: 10.1124/mol.109.056572. Epub 2009 Jun 2.
10
GRK mythology: G-protein receptor kinases in cardiovascular disease.GRK 神话:心血管疾病中的 G 蛋白偶联受体激酶
J Mol Med (Berl). 2009 May;87(5):455-63. doi: 10.1007/s00109-009-0450-7. Epub 2009 Feb 20.